Correlation Between Inhibikase Therapeutics and Purple Biotech
Can any of the company-specific risk be diversified away by investing in both Inhibikase Therapeutics and Purple Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibikase Therapeutics and Purple Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibikase Therapeutics and Purple Biotech, you can compare the effects of market volatilities on Inhibikase Therapeutics and Purple Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibikase Therapeutics with a short position of Purple Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibikase Therapeutics and Purple Biotech.
Diversification Opportunities for Inhibikase Therapeutics and Purple Biotech
-0.67 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Inhibikase and Purple is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Inhibikase Therapeutics and Purple Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Purple Biotech and Inhibikase Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibikase Therapeutics are associated (or correlated) with Purple Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Purple Biotech has no effect on the direction of Inhibikase Therapeutics i.e., Inhibikase Therapeutics and Purple Biotech go up and down completely randomly.
Pair Corralation between Inhibikase Therapeutics and Purple Biotech
Considering the 90-day investment horizon Inhibikase Therapeutics is expected to generate 15.69 times less return on investment than Purple Biotech. But when comparing it to its historical volatility, Inhibikase Therapeutics is 4.69 times less risky than Purple Biotech. It trades about 0.07 of its potential returns per unit of risk. Purple Biotech is currently generating about 0.24 of returns per unit of risk over similar time horizon. If you would invest 297.00 in Purple Biotech on September 4, 2024 and sell it today you would earn a total of 543.00 from holding Purple Biotech or generate 182.83% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inhibikase Therapeutics vs. Purple Biotech
Performance |
| Timeline |
| Inhibikase Therapeutics |
| Purple Biotech |
Inhibikase Therapeutics and Purple Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibikase Therapeutics and Purple Biotech
The main advantage of trading using opposite Inhibikase Therapeutics and Purple Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibikase Therapeutics position performs unexpectedly, Purple Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Purple Biotech will offset losses from the drop in Purple Biotech's long position.| Inhibikase Therapeutics vs. Candel Therapeutics | Inhibikase Therapeutics vs. Cingulate Warrants | Inhibikase Therapeutics vs. Unicycive Therapeutics | Inhibikase Therapeutics vs. Cardio Diagnostics Holdings |
| Purple Biotech vs. Pluri Inc | Purple Biotech vs. BioLineRx | Purple Biotech vs. Enlivex Therapeutics | Purple Biotech vs. Anebulo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |